doi: 10.1007/s12603-020-1313-8
According to FDA prescribing information, gastrointestinal side effects are typically most pronounced during dose initiation and escalation, and they often diminish over time as the body adapts to the medication
Some patients successfully transition off GLP-1 medications after reaching their goals
Then, a woman sues Outback Steakhouse after slipping in a pile of mashed potatoes
De Regil, World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults, JAMA , Dec
Additionally, our biweekly dosing frequency is relatively low compared to other preclinical studies in rats that have used similar or even higher doses on a daily basis to achieve significant weight loss 84,85